
Journal of the American Chemical Society p. 5931 - 5935 (1989)
Update date:2022-07-29
Topics:
Purvis, Michael B.
LeFevre, Joseph W.
Jones, Vickie L.
Kingston, David G. I.
Biot, Andre M.
Gossele, Francis
The formation of the dehydroproline residue of the antibiotic virginiamycin M1 occurs with equal facility from both (R)- and (S)-proline; the 3-pro-R proton of proline is lost stereospecifically in this process. cis-3-Hydroxyproline but not trans-3-hydroxyproline is incorporated into the antibiotic, although less efficiently than proline, and virginiamycin M2 is converted into virginiamycin M1.These results suggest that virginiamycin M1 is most probably formed by incorporation of (S)-proline into virginiamycin M2, which then undergoes hydroxylation withretention of configuration and elimination of water to yield virginiamycin M1.
View MoreContact:+86-21-61318535
Address:Building 29,No.2139 Xizha Road, Fengxian District, Shanghai
SEA BRGIHT INDUSTRY CO.,LIMITED
Contact:0086 755 8622 3990
Address:Rm 17B3,GuangCaiXinTianDi Bldg,GuiMiao Rd,NanShan District,Shenzhen,China
Tengzhou Runlong Fragrance Co., Ltd.
website:http://www.tzrunlong.com/
Contact:--
Address:No. 78, Fushan Road, Biomedical Industrial Park, Dawu Town, Tengzhou, Shandong, 277514 China
Xiamen Huasing Chemicals Co.Ltd.
Contact:0086-592-6228397
Address:NO.24, Xinglin North 2nd Road,Jimei district
Hunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Doi:10.1002/ejoc.200901113
(2010)Doi:10.1021/jo00067a009
(1993)Doi:10.1016/j.tetasy.2009.10.009
(2009)Doi:10.1039/b917549k
(2010)Doi:10.1021/ol100274e
(2010)Doi:10.1039/b919526b
(2010)